Clinical Trials Directory

Trials / Terminated

TerminatedNCT02886078

Dorsal Versus Volar Approach for CapFlex-PIP© Implantation

Dorsal Versus Volar Approach for CapFlex-PIP© Implantation: a Randomized Controlled Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Miriam Marks · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to investigate the active extension six months after implantation of the CapFlex-PIP© arthroplasty, comparing the dorsal with the volar approach. This is a randomized controlled trial including 70 patients with PIP OA indicated for CapFlex arthroplasty.

Detailed description

The CapFlex-PIP© implant is a modular gliding surface proximal interphalangeal (PIP) joint prosthesis. For implantation, there are two approaches available: The dorsal central split approach according to Swanson and the volar approach described by Simmen. Our experiences and data from our prospective registry indicate, that the active extension of the PIP joint is better after the dorsal approach, but sometimes related with hyperextension of the PIP joint and secondary swan-neck deformity. Extension is supposed to be better after the volar approach, but associated with active and passive extension lag. Evidence of theses experiences will assist the surgeon in the preoperative planning to select the appropriate approach according to the patient's needs. The primary objective is to investigate the active extension six months after implantation of the CapFlex-PIP© arthroplasty, comparing the dorsal with the volar approach. This is a randomized controlled trial.

Conditions

Interventions

TypeNameDescription
PROCEDUREDorsal approach CapFlex arthroplastyArthroplasty of the PIP joint with the CapFlex implant. Surgery will be done with the dorsal approach.
PROCEDUREVolar approach CapFlex arthroplastyArthroplasty of the PIP joint with the CapFlex implant. Surgery will be done with the volar approach.

Timeline

Start date
2016-10-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2016-09-01
Last updated
2017-06-16

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02886078. Inclusion in this directory is not an endorsement.